Abiopharma

News list

Jay Colleen 🟡 adjusted position in 4.2K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000002

Full text

News bot April 6, 2026, 9:16 p.m.
🔍 Jay Colleen (Executive)

Company: COOPER COMPANIES, INC. (COO)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 7,479
- Total shares sold: 3,322
Detailed Transactions and Holdings:
- Acquired 3,322 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: false | shares_owned_after: 39,907.00 | transaction_form_type: 4
- Sold 3,322 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Exercise: 2026-04-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
- Acquired 4,157 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | Exercise: 2027-04-01 | equity_swap_involved: false | shares_owned_after: 4,157.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This award has no expiration date. Units will either vest or be forfeited.